Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PHR 160
- Development stage
- Phase 2
- Lead developer
- Alborz University of Medical Sciences
- Modality
- Small Molecules
- Administration
- Intranasal
01
Overview
PHR 160 is a standardized intranasal spray formulation containing an extract of *Rosa damascena* (Damask rose). Developed by researchers at the Alborz University of Medical Sciences, it has been primarily investigated as a supportive therapy for patients with COVID-19. The therapeutic rationale for PHR 160 lies in the phytochemical profile of *Rosa damascena*, which is rich in bioactive compounds such as flavonoids, tannins, and essential oils that possess anti-inflammatory, antioxidant, and potential antiviral properties. The spray is intended for use as an adjunct to standard care to alleviate respiratory symptoms and modulate the local immune response in the upper respiratory tract. Clinical trials conducted during the SARS-CoV-2 pandemic have evaluated its safety and efficacy in reducing the duration and severity of the disease.
- Other names
- Rosa damascena nasal sprayPHR 160 SprayPHR160 SprayPHR-160 Spray
Beyond the preview
Go deeper on PHR 160.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PHR 160.